Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injec... Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.53 | -5.71120689655 | 9.28 | 10.03 | 8.29 | 622379 | 8.99527611 | CS |
| 4 | -0.13 | -1.46396396396 | 8.88 | 10.03 | 8.25 | 448635 | 8.92734005 | CS |
| 12 | -2.26 | -20.5267938238 | 11.01 | 13.6 | 7.2 | 738482 | 9.55565606 | CS |
| 26 | 4.49 | 105.399061033 | 4.26 | 13.6 | 3.54 | 713260 | 8.39883712 | CS |
| 52 | 4.6 | 110.843373494 | 4.15 | 13.6 | 2.612 | 543918 | 6.88276733 | CS |
| 156 | 1.61 | 22.5490196078 | 7.14 | 13.6 | 0.92 | 696312 | 4.64501278 | CS |
| 260 | -4.33 | -33.1039755352 | 13.08 | 25.49 | 0.92 | 773918 | 8.45597006 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
